The trademark application LUNG EPICHECK was filed by Nucleix Limited, a corporation established under the laws of the State of Israel (the "Applicant"). The application was published for oppositions on April 11, 2023, and it was registered by office on July 19, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Diagnostic test kits for medical and clinical use comprised of reagents for use in identifying and measuring changes associated with cancer, precancerous conditions or chronic obstructive pulmonary disease (COPD)
Medical diagnostic assay kits comprised of reagents for use in identifying and measuring changes associated with cancer, precancerous conditions or chronic obstructive pulmonary disease (COPD)
Medical diagnostic kits comprised of medical diagnostic reagents and assays for use in the field of cancer detection or detection of or chronic obstructive pulmonary disease (COPD).
The mark was filed in class 10 with Apparatus for medical diagnostic testing in the field of cancer or chronic obstructive pulmonary disease (COPD).
The mark was filed in class 44 with following description of goods:
Consulting services in the field of health
Consulting services in the field of diagnostic medical testing
Medical analysis for the diagnosis of cancer and chronic obstructive pulmonary disease (COPD) and prognosis of expected progression of the diseases
Medical testing for diagnostic or treatment purposes in the fields of the detection and treatment of cancer and chronic obstructive pulmonary disease (COPD)
Providing cancer screening services
Providing screening services for chronic obstructive pulmonary disease (COPD)
Providing a website featuring information in the fields of the diagnosis and treatment of cancer and chronic obstructive pulmonary disease (COPD).